The agency issued warning letters to Biota Biosciences and Homero for marketing and distributing CBD products as treatments for or alternatives to opioid use
A new report from fashion and beauty publication Glossy is shining a light on the potential impacts that the COVID-19 pandemic could have on retailers’ private label apparel efforts.
Although currently focused on prescription delivery, the program offers potential to expand into front-end merchandise, possibly with a focus on the retailer's own brands.